1/ Johnson &amp; Johnson $JNJ reports tomorrow before the open. Questions on supply chain disruptions, clinical trial disruptions, as well as where they are on their own entry to a Covid-19 vaccine may be answered. Here’s a chart of expected moves, starting with 2 months ~9%: https://t.co/c07PpfXYlA